Companies / Lisata Therapeutics, Inc. / Activity
Activity — Lisata Therapeutics, Inc.
29 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Mazzo David J CEO | Other | Common Stock | $24.1K | -12K -3.68% | 319,744 3.55% of shares | low |
| Jan 9, 2026 | Mazzo David J CEO | Other | Common Stock | $20.7K | -11K -3.07% | 331,968 3.68% of shares | low |
| Jan 9, 2026 | Mazzo David J CEO | Other | Common Stock | $20.7K | -11K -2.98% | 342,483 3.80% of shares | low |
| Jan 9, 2026 | Mazzo David J CEO | Other | Common Stock | $15.5K | -8K -2.46% | 311,890 3.46% of shares | low |
| Jan 9, 2026 | Buck Kristen K Executive | Other | Common Stock | $6.3K | -3K -3.26% | 95,609 1.06% of shares | low |
| Jan 9, 2026 | Buck Kristen K Executive | Other | Common Stock | $5.9K | -3K -2.93% | 98,830 1.10% of shares | low |
| Jan 9, 2026 | Buck Kristen K Executive | Other | Common Stock | $5.9K | -3K -2.85% | 101,812 1.13% of shares | low |
| Jan 9, 2026 | Buck Kristen K Executive | Other | Common Stock | $4.2K | -2K -2.25% | 93,462 1.04% of shares | low |
| Jan 9, 2026 | Nisco James Executive | Other | Common Stock | $4.2K | -2K -5.86% | 34,229 0.38% of shares | low |
| Jan 9, 2026 | Nisco James Executive | Other | Common Stock | $4.2K | -2K -5.54% | 36,360 0.40% of shares | low |
| Jan 9, 2026 | Imam Tariq Executive | Other | Common Stock | $2.8K | -1K -3.54% | 38,178 0.42% of shares | low |
| Jan 9, 2026 | Nisco James Executive | Other | Common Stock | $2.2K | -1K -3.32% | 33,092 0.37% of shares | low |
| Jan 9, 2026 | Imam Tariq Executive | Other | Common Stock | $1.7K | -840 -2.20% | 37,338 0.41% of shares | low |
| Jan 9, 2026 | Nisco James Executive | Other | Common Stock | $1.5K | -781 -2.36% | 32,311 0.36% of shares | low |
| Jan 9, 2026 | Imam Tariq Executive | Other | Common Stock | $1.5K | -747 -2.00% | 36,591 0.41% of shares | low |
| Jan 9, 2026 | Imam Tariq Executive | Other | Common Stock | $1.0K | -513 -1.40% | 36,078 0.40% of shares | low |
| Jan 9, 2026 | Imam Tariq Executive | Grant | Common Stock | $0 | +15K +61.03% | 39,579 0.44% of shares | low |
| Jan 9, 2026 | Nisco James Executive | Grant | Common Stock | $0 | +15K +63.85% | 38,491 0.43% of shares | low |
| Jan 9, 2026 | Buck Kristen K Executive | Grant | Common Stock | $0 | +25K +31.33% | 104,794 1.16% of shares | low |
| Jan 9, 2026 | Flowers Cynthia Louise Director | Grant | Common Stock | $0 | +30K +46.86% | 95,446 1.06% of shares | low |
| Jan 9, 2026 | Brown Gregory B Director | Grant | Common Stock | $0 | +30K +46.71% | 95,659 1.06% of shares | low |
| Jan 9, 2026 | Mazzo David J CEO | Grant | Common Stock | $0 | +81K +29.78% | 352,986 3.92% of shares | low |
| Jan 9, 2026 | Azab Mohammad Director | Grant | Common Stock | $0 | +30K +40.90% | 104,925 1.16% of shares | low |
| Jan 9, 2026 | Henson Heidi Director | Grant | Common Stock | $0 | +30K +55.11% | 85,725 0.95% of shares | low |
| Jan 9, 2026 | Klosk Steven M Director | Grant | Common Stock | $0 | +30K +46.60% | 95,815 1.06% of shares | low |
| Jan 9, 2026 | Imam Tariq Executive | Grant | Stock Option (Right to Buy) | — | +7K | 7,000 0.08% of shares | low |
| Jan 9, 2026 | Nisco James Executive | Grant | Stock Option (Right to Buy) | — | +7K | 7,000 0.08% of shares | low |
| Jan 9, 2026 | Buck Kristen K Executive | Grant | Stock Option (Right to Buy) | — | +13K | 13,000 0.14% of shares | low |
| Jan 9, 2026 | Mazzo David J CEO | Grant | Stock Option (Right to Buy) | — | +40K | 40,000 0.44% of shares | low |